Monogram Health, Inc. Overview
Pro stress-test →Monogram Health is the leading multi-specialty provider of in-home, evidence-based care for patients with multiple chronic conditions. Based in Nashville, Tennessee, the company operates throughout 36 states and is privately held by Frist Cressey Ventures, Norwest Venture Partners, TPG Capital, and other leading strategic and financial investors. Monogram Health meets the needs of more than 200,000 people every year, most of whom have multiple chronic illnesses.
Strategic Profile
Pro stress-test →Monogram Health was ranked as the 7th Fastest Growing Company in the United States by Inc. Magazine in 2025 and achieved No. 1 ranking as the Fastest Growing Company in the Nashville Metro Area by the Nashville Business Journal in 2025. From $4.9 million in 2020, Monogram's revenue surged to nearly $2.2 billion in 2023, driven entirely by organic growth, not acquisitions. The company has differentiated itself through a home-first, patient-centric value-based care model targeting complex polychronic disease management with proven clinical outcomes and cost reduction.
Competitive Landscape
Pro stress-test →Monogram Health operates in the specialized in-home value-based care segment, competing primarily against regional home health providers, integrated delivery systems with home-based programs, and emerging specialty care platforms. Unlike traditional home health agencies, Monogram differentiates through multi-specialty physician-led teams, technology-driven case management, and explicit value-based risk models with major health plans (Aetna/CVS Health, etc.). Key competitive advantages include proprietary evidence-based clinical interventions, proven outcomes (98% enrollment growth, 21.8% reduction in hospital readmissions), and partnerships with top-tier payers covering 36+ states.
Industry Context
Monogram Health, Inc. operates in Value-based specialty care delivery for chronic disease.
Key facts
Founded: 2019 · Headquarters: Nashville, Tennessee, US · Employees: 1,500+ (as of August 2024) · Revenue: $2.2 billion (2023); anticipated over $3 billion (2024)